Approval · Notice of Compliance 28744 · 2022
M-TICAGRELOR: Notice of Compliance 28744
Issued August 12, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28744
- Date
- August 12, 2022
- Company
- Mantra Pharma Inc.Brossard, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- BRILINTA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| M-TICAGRELOR | 02529750 | Marketed |
| M-TICAGRELOR | 02529769 | Marketed |
Medicinal ingredients
- TICAGRELOR 60 MG per TAB
- TICAGRELOR 90 MG per TAB